Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Modified personalized cancer vaccine generates powerful immune response
2.
Is There a Role for Stimulants in Beating Cancer Fatigue?
3.
HER2 ADC Shows Promise in Recurrent Endometrial Cancer
4.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
5.
According to JAMA, even four minutes a day of exercise can lower the risk of cancer.
1.
Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence
2.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
3.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
4.
Ultimate Guide to Oncology Services in the USA
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Current Scenario of Cancer- Q&A Session to Close the Gap
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation